Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, Sonia Mazzucchi, Daniela Frosini, Riccardo Morganti, Piero Coleschi, Laura Maria Raglione, Paola Vanni, Silvia Ramat, Alessio Novelli, Alessandro Napolitano, Carla Battisti, Martina Giuntini, Carlo Rossi, C. Menichetti, Monica Ulivelli, Valentino De Franco, Símone Rossi, Ubaldo Bonuccelli, Roberto Ceravolo, Tuscany Parkinson COVID-19 Participants
Topics & Concepts
MedicinePopulationTelemedicineNeurologyCoronavirus disease 2019 (COVID-19)Case fatality ratePandemicDiabetes mellitusDiseasePhysical therapyInternal medicineHealth careEnvironmental healthPsychiatryInfectious disease (medical specialty)EndocrinologyEconomicsEconomic growthParkinson's Disease Mechanisms and TreatmentsLong-Term Effects of COVID-19Parkinson's Disease and Spinal Disorders